AI Used to Identify 3 MS Subtypes
Source: Pixabay.com

AI Used to Identify 3 MS Subtypes

Currently, multiple sclerosis (MS), an autoimmune and neurological disorder, is considered either progressive or relapsing-remitting. But could there be additional subtypes? According to new research, yes. As explained in Medical…

Continue Reading AI Used to Identify 3 MS Subtypes
A Molecular Signature on Stressed Liver Cells Provides PSC Patients With A New Clue to Their Condition
source: pixabay.com

A Molecular Signature on Stressed Liver Cells Provides PSC Patients With A New Clue to Their Condition

The rare liver disease primary sclerosing cholangitis (PSC) may impact just .01% of people, but the extremely pernicious disorder's attacks on the liver mean bearers of the disorder account for…

Continue Reading A Molecular Signature on Stressed Liver Cells Provides PSC Patients With A New Clue to Their Condition

Studies Show That Sucrose May Be Partly Responsible for Chronic Liver Disease in Children

According to a recent report in Medical Xpress, over twenty studies have indicated escalating events of nonalcoholic fatty liver disease (NAFLD) in children worldwide. In the United States, NAFLD heads…

Continue Reading Studies Show That Sucrose May Be Partly Responsible for Chronic Liver Disease in Children
Ayvakit for Gastrointestinal Stromal Tumors Approved in China
source: pixabay.com

Ayvakit for Gastrointestinal Stromal Tumors Approved in China

According to a story from Markets Insider, the biopharmaceutical company CStone Pharmaceuticals has announced that China's National Medical Products Administration (NMPA) has approved avapritinib (marketed as Ayvakit) as a treatment…

Continue Reading Ayvakit for Gastrointestinal Stromal Tumors Approved in China